MARÍA JOSÉ
HERRERO CERVERA
AYUDANTE DOCTOR/A
Gustave Roussy Cancer Campus
Villejuif, FranciaPublications en collaboration avec des chercheurs de Gustave Roussy Cancer Campus (4)
2023
2021
-
Pharmacogenetics in neuroblastoma: What can already be clinically implemented and what is coming next?
International Journal of Molecular Sciences, Vol. 22, Núm. 18
2020
-
MTHFR and VDR polymorphisms improve the prognostic value of MYCN status on overall survival in neuroblastoma patients
International Journal of Molecular Sciences, Vol. 21, Núm. 8
2019
-
Pharmacogenetics implementation in the clinics: information and guidelines for germline variants
Cancer Drug Resistance, Vol. 2, Núm. 1, pp. 53-68